DOCSLIB.ORG

EFNS Review on the Role of Muscle Biopsy in the Investigation of Myalgia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
EFNS Review on the Role of Muscle Biopsy in the Investigation of Myalgia European Journal of Neurology 2013, 20: 997–1005 doi:10.1111/ene.12174 EFNS REVIEW/CME ARTICLE EFNS review on the role of muscle biopsy in the investigation of myalgia T. Kyriakidesa, C. Angelinib, J. Schaeferc, T. Monginid, G. Sicilianoe, S. Sacconif, J. Josephg, J. M. Burgunderh, L. A. Bindoffi, J. Vissingj, M. de Visserk and D. Hilton-Jonesl aClinical Neurosciences, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; bIRCCS Fondazione Ospedale San Camillo, Venezia, Italy; cDepartment of Neurology, University of Dresden, Dresden, Germany; dNeuromuscular Center, S.G. Battista Hospital, University of Turin, Turin, Italy; eDepartment of Neuroscience, Neurological Clinic, University of Pisa, Pisa, Italy; fCentre de reference des Maladies nueuromusculaires, CNRS UMR6543, Nice University Hospital, Nice, France; gSt George’s University of London at the University of Nicosia Medical School, Nicosia, Cyprus; hDepartments of Neurology and Clinical Research, University of Bern, Inselspital, Bern, Switzerland; iDepartment of Neurology, Haukeland University Hospital, Bergen, Norway; jNeuromuscular Clinic and Research Unit, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; kDepartment of Neurology, Academic Medical Center, Amsterdam, The Netherlands; and lOxford Neuromuscular Centre, Department of Neurology, John Radcliffe Hospital, Oxford, UK Keywords: Background: Myalgia, defined as any pain perceived in muscle, is very common in biopsy, muscle, myalgia the general population and a frequent cause for referral to neurologists, rheumatol- ogists and internists in general. It is however only rarely due to primary muscle dis- Received 8 February 2013 ease and often referred from ligaments, joints, bones, the peripheral and central Accepted 14 February 2013 nervous system. A muscle biopsy should only be performed if this is likely to be diagnostically useful. At present no ‘guidelines’ exist. Methods: An EFNS panel of muscle specialists was set to review relevant studies from PubMed dating as far back as 1/1/1990. Only Class IV studies were available and therefore the recommendations arrived at are ‘best practice recommendations’ based on information harvested from the literature search and expert opinion. Results: Muscle cramps should be recognized while drugs, infections, metabolic/ endocrinological and rheumatological causes of myalgia should be identified from the history and examination and pertinent laboratory tests. A muscle biopsy is more likely to be diagnostically useful if myalgia is exertional and if one or more of the following apply: i) there is myoglobinuria, (ii) there is a second wind phenomenon, (iii) there is muscle weakness, (iv) there is muscle hypertrophy /atrophy, (v) there is hyperCKemia (>2–39 normal), and (vi) there is a myopathic EMG. Conclusions: Patients presenting with myalgia can be recommended to have a biopsy based on careful history and examination and on simple laboratory screen- ing. pain is frequently referred from elsewhere, including Objective non-muscular tissues such as ligaments, tendons, To provide guidelines on the role of muscle biopsy in joints and bones or the peripheral and even the cen- the elucidation of the cause of myalgia. The guidelines tral nervous system [1–3]. Less commonly, it is due to cover both adult and pediatric populations. a primary problem within the muscle itself and its Myalgia is a common symptom but is only rarely associated connective tissue and blood vessels [1]. due to underlying primary muscle disease. Rather, the Population-based studies estimate the incidence of diffuse persistent muscle pain to be about 10% [4]. Correspondence: T. Kyriakides, 6 International Airport Avenue, PO Elucidating the cause of myalgia, particularly in the Box 23462, 1683 Nicosia, Cyprus (tel.: +35722392758; fax: absence of other associated features, can be a difficult +35722392786; e-mail: [email protected]). task, but an invasive and expensive procedure such as This is a Continuing Medical Education article, and can be found with corresponding questions on the Internet at http://www.efns.org/EFNS a muscle biopsy, be it with a low morbidity, should Continuing-Medical-Education-online.301.0.html. Certificates for cor- be performed only if it is likely to be diagnostically rectly answering the questions will be issued by the EFNS. useful [5,6]. © 2013 The Author(s) European Journal of Neurology © 2013 EFNS 997 998 T. Kyriakides et al. and no relevant guidelines were found. The only avail- Definitions able guidelines identified were those of the German Myalgia may be defined as any pain perceived to be Neurological Society on the ‘Clinical pathway for the in muscle. investigation of myalgias’ [9]. Muscle cramps are one cause of myalgia and consist The Medline database was accessed between 12 of sudden onset, transient, involuntary, painful and February 2012 and 16 July 2012 with the following vigorous muscle contraction. Cramps may occur spon- key terms: myalgia, and one of myopathy, biopsy, taneously at rest or more often during or after exer- weakness, exercise, drugs, dystrophy, EMG and cise, and usually last from seconds to a few minutes. hyperCKemia; muscle and pain, and one of weakness, Such ‘true’ cramps are neurogenic in origin and are biopsy, exercise, drugs, dystrophy, EMG, myopathy associated with high frequency motor unit discharges and hyperCKemia; myalgia and exercise, and one of [7,8]. myopathy, biopsy, weakness, drugs, dystrophy and The word contracture is used in two unrelated EMG. More than 27 000 reports were identified but senses. Transient, electrically silent contractures, there was much redundancy within individual searches which are painful and clinically resemble cramps, are and between searches. Abstracts were reviewed and characteristically present in metabolic myopathies and relevant articles were identified. To evaluate articles, are evoked by exercise. Persistent contractures, which the critical review of EFNS guidelines was followed may be focal or more usually involve the whole mus- [10]. A hand search was also performed by members cle, causing shortening of the muscle and thus limita- of the Task Force. As predicted, only class IV studies tion of passive joint movements, are a common late were identified and therefore this review is a best prac- feature of many myopathies, such as dystrophies. tice guideline based on the review of the literature and They are an early feature in Emery–Dreifuss syn- the Task Force’s expert opinion. A first draft was pre- drome. Such contractures are usually painless. pared and circulated on 3 September 2012. The draft was reviewed at a meeting on 10 September 2012 and recirculated to members until final consensus was Search strategy reached. The Task Force members met on 12 September 2011 and decided on a literature search policy. This Myalgia and exercise included a search for any existing guidelines and arti- cles dealing with the indications for muscle biopsy in Myalgia can occur at rest, during or after exercise. It patients with myalgia. It was decided that the litera- can be focal or generalized. The circumstances in ture search should go as far back as 1 January 1990 which myalgia develops provide helpful clues to the and Medline was chosen as the sole database to be etiology. Myalgia at rest, especially in the absence of searched. It was felt that clinically important studies weakness, is rarely due to a primary myopathy. were unlikely to be left out with this arbitrary decision There are three major patterns of myalgia in rela- and furthermore the Task Force did not expect to tion to exercise [11]: identify any class I–III studies in the literature. The 1 Pain experienced during (exertional) or immedi- lack of robust prior studies may paradoxically make ately following (post-exertional) exercise. Myalgia these guidelines particularly useful, pending evidence- associated with primary myopathies is commonly based knowledge. exertional (see below). Myalgia associated with pri- It was decided to identify and succinctly summarize mary metabolic myopathies may be associated commonly reported, non-neuromuscular causes of with transient contractures. myalgia, including rheumatological diseases, com- 2 Delayed muscle pain (delayed post-exertional) usu- monly used drugs and general medical conditions. The ally occurs 24–48 h after strenuous or eccentric main emphasis of the search, however, was to identify exercise. Soreness is usually accompanied by loss primary myopathies presenting with or associated of strength and elevated levels of serum creatine with myalgia. Special attention was paid to studies in kinase (sCK) activity. It commonly occurs in unfit which clinical features (e.g. the relation of myalgia to individuals undertaking unaccustomed exercise and exercise or weakness) or investigations [e.g. hyperC- is not a hallmark of primary muscle disease. It is Kemia, electromyography (EMG)] were detailed, in thought to be due to microtrauma and local order to be able to identify patients in whom a biopsy inflammation. could be recommended. The Cochrane Library and 3 Muscle cramps per se are of heterogeneous origin the American Academy of Neurology were accessed (Table 1) and may be associated with specific on 17 March 2011 and again on 3 September 2012 neurogenic disorders (Table 2). © 2013 The Author(s) European Journal of Neurology © 2013 EFNS European Journal of Neurology Muscle biopsy in myalgia 999 Table 1 Common causes of muscle cramps Table 4 Infections commonly associated with myalgia
Load more

Recommended publications
  • Statin Myopathy: a Common Dilemma Not Reflected in Clinical Trials
    REVIEW CME EDUCATIONAL OBJECTIVE: Readers will assess possible statin-induced myopathy in their patients on statins CREDIT GENARO FERNANDEZ, MD ERICA S. SPATZ, MD CHARLES JABLECKI, MD PAUL S. PHILLIPS, MD Internal Medicine Residency Program, Robert Wood Johnson Clinical Scholars Department of Neurosciences, University Director, Interventional Cardiology, The University of Utah, Salt Lake City Program, Cardiovascular Disease Fellow, of California San Diego, La Jolla Department of Cardiology, Scripps Mercy Yale University School of Medicine, New Hospital, San Diego, CA Haven, CT Statin myopathy: A common dilemma not reflected in clinical trials ■■ ABSTRACT hen a patient taking a statin complains Wof muscle aches, is he or she experiencing Although statins are remarkably effective, they are still statin-induced myopathy or some other prob- underprescribed because of concerns about muscle toxic- lem? Should statin therapy be discontinued? Statins have proven efficacy in preventing ity. We review the aspects of statin myopathy that are 1 important to the primary care physician and provide a heart attacks and death, and they are the most guide for evaluating patients on statins who present with widely prescribed drugs worldwide. Neverthe- less, they remain underused, with only 50% of muscle complaints. We outline the differential diagnosis, those who would benefit from being on a statin the risks and benefits of statin therapy in patients with receiving one.2,3 In addition, at least 25% of possible toxicity, and the subsequent treatment options. adults who start taking statins stop taking them 4 ■■ by 6 months, and up to 60% stop by 2 years. KEY POINTS Patient and physician fears about myopathy There is little consensus on the definition of statin-in- remain a key reason for stopping.
    [Show full text]
  • Focal Eosinophilic Myositis Presenting with Leg Pain and Tenderness
    CASE REPORT Ann Clin Neurophysiol 2020;22(2):125-128 https://doi.org/10.14253/acn.2020.22.2.125 ANNALS OF CLINICAL NEUROPHYSIOLOGY Focal eosinophilic myositis presenting with leg pain and tenderness Jin-Hong Shin1,2, Dae-Seong Kim1,2 1Department of Neurology, Research Institute for Convergence of Biomedical Research, Pusan National University Yangsan Hospital, Yangsan, Korea 2Department of Neurology, Pusan National University School of Medicine, Yangsan, Korea Focal eosinophilic myositis (FEM) is the most limited form of eosinophilic myositis that com- Received: September 11, 2020 monly affects the muscles of the lower leg without systemic manifestations. We report a Revised: September 29, 2020 patient with FEM who was studied by magnetic resonance imaging and muscle biopsy with Accepted: September 29, 2020 a review of the literature. Key words: Myositis; Eosinophils; Magnetic resonance imaging Correspondence to Dae-Seong Kim Eosinophilic myositis (EM) is defined as a group of idiopathic inflammatory myopathies Department of Neurology, Pusan National associated with peripheral and/or intramuscular eosinophilia.1 Focal eosinophilic myositis Univeristy School of Medicine, 20 Geu- mo-ro, Mulgeum-eup, Yangsan 50612, (FEM) is the most limited form of EM and is considered a benign disorder without systemic 2 Korea manifestations. Here, we report a patient with localized leg pain and tenderness who was Tel: +82-55-360-2450 diagnosed as FEM based on laboratory findings, magnetic resonance imaging (MRI), and Fax: +82-55-360-2152 muscle biopsy. E-mail: [email protected] ORCID CASE Jin-Hong Shin https://orcid.org/0000-0002-5174-286X A 26-year-old otherwise healthy man visited our outpatient clinic with leg pain for Dae-Seong Kim 3 months.
    [Show full text]
  • A Acanthosis Nigricans, 139 Acquired Ichthyosis, 53, 126, 127, 159 Acute
    Index A Anti-EJ, 213, 214, 216 Acanthosis nigricans, 139 Anti-Ferc, 217 Acquired ichthyosis, 53, 126, 127, 159 Antigliadin antibodies, 336 Acute interstitial pneumonia (AIP), 79, 81 Antihistamines, 324 Adenocarcinoma, 115, 116, 151, 173 Anti-histidyl-tRNA-synthetase antibody Adenosine triphosphate (ATP), 229 (Anti-Jo-1), 6, 14, 140, 166, 183, Adhesion molecules, 225–226 213–216 Adrenal gland carcinoma, 115 Anti-histone antibodies (AHA), 174, 217 Age, 30–32, 157–159 Anti-Jo-1 antibody syndrome, 34, 129 Alanine aminotransferase (ALT, ALAT), 16, Anti-Ki-67 antibody, 247 128, 205, 207, 255 Anti-KJ antibodies, 216–217 Alanyl-tRNA synthetase, 216 Anti-KS, 82 Aldolase, 14, 16, 128, 129, 205, 207, 255, 257 Anti-Ku antibodies, 163, 165, 217 Aledronate, 325 Anti-Mas, 217 Algorithm, 256, 259 Anti-Mi-2 Allergic contact dermatitis, 261 antibody syndrome, 11, 129, 215 Alopecia, 62, 199, 290 antibodies, 6, 15, 129, 142, 212 Aluminum hydroxide, 325, 326 Anti-Myo 22/25 antibodies, 217 Alzheimer’s disease-related proteins, 190 Anti-Myosin scintigraphy, 230 Aminoacyl-tRNA synthetases, 151, 166, 182, Antineoplastic agents, 172 212, 215 Antineoplastic medicines, 169 Aminoquinolone antimalarials, 309–310, 323 Antinuclear antibody (ANA), 1, 141, 152, 171, Amyloid, 188–190 172, 174, 213, 217 Amyopathic DM, 6, 9, 29–30, 32–33, 36, 104, Anti-OJ, 213–214, 216 116, 117, 147–153 Anti-p155, 214–215 Amyotrophic lateral sclerosis, 263 Antiphospholipid syndrome (APS), 127, Antisynthetase syndrome, 11, 33–34, 81 130, 219 Anaphylaxi, 316 Anti-PL-7 antibody, 82, 214 Anasarca,
    [Show full text]
  • Muscle Biopsy Features of Idiopathic Inflammatory Myopathies And
    Autoimmun Highlights (2014) 5:77–85 DOI 10.1007/s13317-014-0062-2 REVIEW ARTICLE Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis Gaetano Vattemi • Massimiliano Mirabella • Valeria Guglielmi • Matteo Lucchini • Giuliano Tomelleri • Anna Ghirardello • Andrea Doria Received: 1 August 2014 / Accepted: 22 August 2014 / Published online: 10 September 2014 Ó Springer International Publishing Switzerland 2014 Abstract The gold standard to characterize idiopathic Keywords Inflammatory myopathy Á Autoimmune inflammatory myopathies is the morphological, immuno- myositis Á Histopathology Á Differential diagnosis histochemical and immunopathological analysis of muscle biopsy. Mononuclear cell infiltrates and muscle fiber necrosis are commonly shared histopathological features. Introduction Inflammatory cells that surround, invade and destroy healthy muscle fibers expressing MHC class I antigen are Idiopathic inflammatory myopathies (IIM) are a heteroge- the typical pathological finding of polymyositis. Perifas- neous group of acquired muscle diseases, which have dis- cicular atrophy and microangiopathy strongly support a tinct clinical, pathological and histological features [1, 2]. diagnosis of dermatomyositis. Randomly distributed The most common IIM seen in clinical practice can be necrotic muscle fibers without mononuclear cell infiltrates separated into four categories including polymyositis (PM), represent the histopathological hallmark of immune-med- dermatomyositis (DM), immune-mediated necrotizing iated necrotizing myopathy; meanwhile, endomysial myopathy (NM) and sporadic inclusion body myositis inflammation and muscle fiber degeneration are the two (sIBM) [1, 3]. main pathological features in sporadic inclusion body In the diagnostic workup of an inflammatory myopathy, myositis. A correct differential diagnosis requires immu- muscle biopsy is an indispensable and sensitive tool for nopathological analysis of the muscle biopsy and has establishing the diagnosis.
    [Show full text]
  • SUPPLEMENTARY MATERIAL Supplementary 1. International
    SUPPLEMENTARY MATERIAL Supplementary 1. International Myositis Classification Criteria Project Steering Committee Supplementary 2. Pilot study Supplementary 3. International Myositis Classification Criteria Project questionnaire Supplementary 4. Glossary and definitions for the International Myositis Classification Criteria Project questionnaire Supplementary 5. Adult comparator cases in the International Myositis Classification Criteria Project dataset Supplementary 6. Juvenile comparator cases in the International Myositis Classification Criteria Project dataset Supplementary 7. Validation cohort from the Euromyositis register Supplementary 8. Validation cohort from the Juvenile dermatomyositis cohort biomarker study and repository (UK and Ireland) 1 Supplementary 1. International Myositis Classification Criteria Project Steering Committee Name Affiliation Lars Alfredsson Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Anthony A Amato Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA Richard J Barohn Department of Neurology, University of Kansas Medical Center, Kansas City, USA Matteo Bottai Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Matthew H Liang Division of Rheumatology, Immunology and Allergy, Brigham and Women´s Hospital, Boston, USA Ingrid E Lundberg (Project Director) Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden Frederick W Miller Environmental
    [Show full text]
  • NEUROLOGY NEUROSURGERY & PSYCHIATRY Editorial
    Journal ofNeurology, Neurosurgery, and Psychiatry 1991;54:285-287 285 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.54.4.285 on 1 April 1991. Downloaded from Joural of NEUROLOGY NEUROSURGERY & PSYCHIATRY Editorial The idiopathic inflammatory myopathies and their treatment The inflammatory myopathies are the largest group of As new knowledge has accumulated over the course of acquired myopathies of adult life and may also occur in the last 10 years, it has become increasingly clear that there infancy and childhood. They have in common the presence are distinct pathological and immunological differences of inflammatory infiltrates within skeletal muscle, usually between polymyositis on the one hand and dermato- in association with muscle fibre destruction. They can be myositis on the other, though in some cases there is clearly subdivided into those which are due to known viral, an overlap between the two conditions. In polymyositis bacterial, protozoal or other microbial agents and those in there is usually scattered necrosis of single muscle fibres which no such agent can be identified and in which which appear hyalinised in the early stages and are immunological mechanisms have been implicated.' The subsequently invaded by mononuclear phagocytic cells. latter group includes polymyositis, dermatomyositis and Regenerating fibres are usually seen singly or in small inclusion body myositis. The evidence for an autoimmune groups distributed focally and randomly throughout the aetiology consists of: 1) an association with other auto- muscle. The inflammatory cell infiltrate is predominantly immune diseases; 2) serological tests which reflect an intrafascicular (endomysial) surrounding muscle fibres altered immune state; and 3) the responsiveness of rather than in the interfascicular septa, though perivascular polymyositis and dermatomyositis, if not of the inclusion infiltrates may also be found; the cellular infiltrate consists body variety, to immunotherapy.2 Polymyositis may rarely mainly of lymphocytes, plasma cells and macrophages.
    [Show full text]
  • EM Guidemap - Myopathy and Myoglobulinuria
    myopathy EM guidemap - Myopathy and myoglobulinuria Click on any of the headings or subheadings to rapidly navigate to the relevant section of the guidemap Introduction General principles ● endocrine myopathy ● toxic myopathy ● periodic paralyses ● myoglobinuria Introduction - this short guidemap supplements the neuromuscular weakness guidemap and offers the reader supplementary information on myopathies, and a short section on myoglobulinuria - this guidemap only consists of a few brief checklists of "causes of the different types of myopathy" that an emergency physician may encounter in clinical practice when dealing with a patient with acute/subacute muscular weakness General principles - a myopathy is suggested when generalized muscle weakness involves large proximal muscle groups, especially around the shoulder and proximal girdle, and when the diffuse muscle weakness is associated with normal tendon reflexes and no sensory findings - a simple classification of myopathy:- Hereditary ● muscular dystrophies ● congenital myopathies http://www.homestead.com/emguidemaps/files/myopathy.html (1 of 13)8/20/2004 5:14:27 PM myopathy ● myotonias ● channelopathies (periodic paralysis syndromes) ● metabolic myopathies ● mitochondrial myopathies Acquired ● inflammatory myopathy ● endocrine myopathies ● drug-induced/toxic myopathies ● myopathy associated with systemic illness - a myopathy can present with fixed weakness (muscular dystrophy, inflammatory myopathy) or episodic weakness (periodic paralysis due to a channelopathy, metabolic myopathy
    [Show full text]
  • Connective Tissue 5.2.04
    Other Connective Tissue Diseases Chester V. Oddis, MD Thomas A. Medsger, Jr, MD Arthur Weinstein, MD Contents 1. Undifferentiated Connective Tissue Disease 2. Idiopathic Inflammatory Myopathy 3. Scleroderma 4. Sjögren’s Syndrome 5. References OTHER CONNECTIVE TISSUE DISEASES 1 1. Undifferentiated Connective Tissue Disease Table 1 The American College of Rheumatology (ACR) has published criteria for several different diseases Clinical Features and Autoantibody Findings commonly referred to as connective tissue disease Possibly Specific for a Defined CTD (CTD). The primary aim of such classification crite - ria is to ensure the comparability among CTD stud - ies in the scientific community. These diseases Clinical Feature include rheumatoid arthritis (RA), systemic sclero - sis (SSc), systemic lupus erythematosus (SLE), Malar rash polymyositis (PM), dermatomyositis (DM), and Sjögren’s syndrome (SS). These are systemic Subacute cutaneous lupus rheumatic diseases which reflects their inflamma - tory nature and protean clinical manifestations with Sclerodermatous skin changes resultant tissue injury. Although there are unifying immunologic features that pathogenetically tie Heliotrope rash these separate CTDs to each other, the individual disorders often remain clinically and even serologi - Gottron’s papules cally distinct. Immunogenetic data and autoanti - body findings in the different CTDs lend further Erosive arthritis support for their distinctive identity and often serves to subset the individual CTD even further, as seen with the myositis syndromes, SLE and SSc. In other cases, it remains difficult to classify individuals Autoantibody with a combination of signs, symptoms, and labora - tory test results. It is this group of patients that have Anti-dsDNA an “undifferentiated” connective tissue disease (UCTD), or perhaps more accurately, an undifferen - Anti-Sm tiated systemic rheumatic disease.
    [Show full text]
  • The Editors of the Journal Ofclinical Investigation Gratefully
    The Editors ofThe Journal ofClinical Investigation gratefully acknowledge the assistance ofthefollowing reviewers who served during the periodfrom 1 August 1989 through 31 July 1990. Stuart Aaronson Gordon Amidon Lloyd Axelrod Daniel Beauchamp Nanette H. Paul Bormstein Francois M. Claude Amiel Ole Baadsgaard Arthur Beaudet Bishopric Gerry R. Boss Abboud Arthur J. Ammann Bernard M. Babior Daniel Bechard D. Montgomery G. F. Bottazzo Hanna E. Abboud Helmut V. Ammon Robert J. Bache Lewis C. Becker Bissell Elias H. Botvinick George Abela Athanasius Bruce R. Bacon Richard Behringer Mina J. Bissell Claude Bouchard Dana R. Anagnostou David Bader David A. Bell Peter Bitterman Richard C. Abendschein Clark L. Anderson Kamal F. Badr Graeme I. Bell Ingemar Bjorkhem Boucher J. A. Abildskov Donald C. Steinun Norman H. Bell Robert E. Black Andrew J. M. Janis Abkowitz Anderson Baekkeskov William R. Bell William G. Boulton Robert T. Abraham Jeffrey L. Anderson Jacques U. Joseph A. Bellanti Blackard Bonno N. Bouma Dale R. Robert J. Anderson Baenziger Sam Benchimol George L. Daniel Bowen- Abrahamson Sharon Anderson Grover C. Bagby Earl P. Benditt Blackburn Pope Donald I. Abrams Giuseppe Andres Marco Baggiolini William E. Benitz Perry Blackshear Laurence Boxer Christine Abrass Reubin Andres Corrado Baglioni Joel S. Bennett Paul Blake Linda Boxer Naji N. Abumrad Aubie Angel Andrew D. Baines John E. Bennett J. Edwin Blalock Aubrey E. Boyd Hugh Ackerman Harry N. Dorothy Bainton Michael Bennett Rebecca Blanton James L. Boyer Steven Ackerman Antoniades Andrew Baird Vann Bennett Roland C. Blantz Thomas Boyer Brian A. Ackrell Asok C. Antony Robert S. Balaban Neal L. Benowitz Terrence F.
    [Show full text]
  • Occupational Diseases
    OCCUPATIONAL DISEASES OCCUPATIONAL DISEASES ОДЕСЬКИЙ ДЕРЖАВНИЙ МЕДИЧНИЙ УНІВЕРСИТЕТ THE ODESSA STATE MEDICAL UNIVERSITY Áiáëiîòåêà ñòóäåíòà-ìåäèêà Medical Student’s Library Започатковано 1999 р. на честь 100-річчя Одеського державного медичного університету (1900–2000 рр.) Initiated in 1999 to mark the Centenary of the Odessa State Medical University (1900–2000) 1 OCCUPATIONAL DISEASES Recommended by the Central Methodical Committee for Higher Medical Education of the Ministry of Health of Ukraine as a manual for students of higher medical educational establishments of the IV level of accreditation using English Odessa The Odessa State Medical University 2009 BBC 54.1,7я73 UDC 616-057(075.8) Authors: O. M. Ignatyev, N. A. Matsegora, T. O. Yermolenko, T. P. Oparina, K. A. Yarmula, Yu. M. Vorokhta Reviewers: Professor G. A. Bondarenko, the head of the Department of Occupational Diseases and Radiation Medicine of the Donetzk Medical University named after M. Gorky, MD Professor I. F. Kostyuk, the head of the Department of Internal and Occupational Diseases of the Kharkiv State Medical University, MD This manual contains information about etiology, epidemiology, patho- genesis of occupational diseases, classifications, new methods of exami- nation, clinical forms and presentation, differential diagnosis, complica- tions and treatment. It includes the questions of prophylaxis, modern trends in treatment according to WHO adopted instructions, working capacity expert exam. The represented material is composed according to occupational dis- eases study programme and it is recommended for the students of higher medical educational establishments of the IV accreditation standard and doctors of various specialities. Рекомендовано Центральним методичним кабінетом з вищої медичної освіти МОЗ України як навчальний посібник для студентів вищих медичних навчальних закладів IV рівня акредитації, які опановують навчальну дисципліну англiйською мовою (Протокол № 4 від 24.12.2007 р.
    [Show full text]
  • Pathological Evaluation of Probiotic, Bacillus Subtilis, Against
    Journal of American Science, 2011; 7(2) http://www.americanscience.org Pathological Evaluation of Probiotic, Bacillus Subtilis, against Flavobacterium columnare in Tilapia Nilotica (Oreochromis Niloticus) Fish in Sharkia Governorate, Egypt Mohamed H Mohamed and Nahla AG Ahmed Refat Dept of Vet. Pathology, Fac Vet Medicine, Zagazig University, 44519 Zagazig City, Egypt. Nahla_kashmery@hotmail [email protected] Abstract: Fifteen out-of eighty-five of collected Tilapia nilotica fish (17.64%) showing skin lesions, were positive for Flavobacterium columnare with cultural, morphological and biochemical characteristics. These skin lesions were large erosions with loss of scales and red-grayish patches, particularly at the frontal head region and abdomen. All of the positive isolates (Flavobacterium columnare) were molecularly tested by means of PCR. With consistent with F. columnare standard ATCC 49512 strain, these isolates produced a 675 bp band. One hundred apparently healthy Tilapia nilotica fingerlings (30±5 gm) were used to evaluate the effectiveness of probiotic, Bacillus subtilis, in water or diet against the intramuscular challenge with Flavobacterium columnare infection. They were equally divided into 10 groups (10 fish for each group). Five groups were experimental control {placebo (gp 1), intramuscularly infected with 0.2 x108 F. columnare CFU (gp 2), received 0.1 gm/L probiotic in water (gp 3), 0.2 gm /L probiotic in fish diet (gp 4), or 1 gm/L oxytetracycline (gp 5)}; two were prophylactic experiment {received 0.1 (gp 6) or 0.2 (gp 7) gm of probiotic in water and diet, respectively 2 months before bacterial infection and continued for a week later}; and three were treated experiment {intramuscularly infected with 0.2 x108 F.
    [Show full text]
  • Notes on Rheumatology Author: Liz Tatman © Dr R
    Notes on Rheumatology Author: Liz Tatman Musculoskeletal (MSK) Problems: Principles of Management MSK symptoms Pain – site, radiation (get radiation distally, more common with more proximal joints e.g. shoulder and knee), quality (shooting with nerve entrapment). Onset. With usage (mechanical), at rest (inflammatory) or at night (if no relation to movement concern about bony mets). Bony pain – well localised, doesn’t radiate, progressive, night predominant, not related to movement, due to fractures, neoplasia, Paget’s disease, osteomalacia, osteomyelitis, osteonecrosis. Referred pain – poorly localised, diffuse, improved by rubbing. Can get neuropathic pain sometime after injury. Stress pain – in tight pack positions, if in all directions suggests synovitis. Stiffness – prolonged early morning and inactivity imply inflammatory cause. Swelling and deformity. Instability Locking – sudden inability to move joint, usually painful but transient, post unlocking discomfort. Affects hinge joints (knee, elbow, TMJ). Mechanical problem e.g. synovium, cartilage, split meniscus. Loss of function, disability and handicap. Systemic illness – night sweats, malaise, fatigue, weight loss suggest inflammatory process. Sleep disturbance. Red flags: progressive, well localised progressive night-predominant pain (mets), red hot joint (sepsis), sequential joint involvement (spreading sepsis). History – need to determine if traumatic or non-traumatic, ask about dominant hand. Trauma – time, place, mechanism (twist, blow, crush), magnitude of force, direction of force, first aid, immediate symptoms and progression, previous injuries. Non-trauma – rule out (RESTIT) Referred pain, Embolus, Sepsis, Tumour, Ischaemia, Thrombosis. Systems enquiry for non MSK causes, associated features, drug toxicity, pre-op assessment and involvement of other organs. Especially general malaise (anaemia), hot and shivery (infection), skin (rashes, psoriasis, Raynaud’s), eyes (iritis, scleritis).
    [Show full text]